title: Splinting and local steroid injection for the treatment of ulnar neuropathy at the elbow: clinical and electrophysiological evaluation.
abstract: OBJECTIVE
  To compare the effects of splinting alone in the treatment of ulnar nerve lesion at the elbow with the effects of applying a local steroid injection in addition to splinting.
  
  
  METHODS
  Twelve nerves of 10 patients were randomly assigned into two groups: 5 nerves in Group A were treated with elbow splinting only; 7 nerves in Group B were treated with local steroid injection in addition to splinting. Therapeutic effects were assessed 1 and 6 months after treatment.
  
  
  METHODS
  Patients were selected from an outpatient clinic of a VA Medical Center.
  
  
  METHODS
  Ten patients (12 nerves) with ulnar neuropathy at the elbow confirmed by electrodiagnostic tests.
  
  
  METHODS
  Elbow splint was given to patients of both Groups A and B. A single dose of 40 mg triamcinolone plus 1 mL of 1% lidocaine was injected around the ulnar nerve at the elbow of Group A patients.
  
  
  METHODS
  Clinical evaluation of symptoms and signs, and ulnar motor and sensory nerve conduction studies were performed before, 1 month after, and 6 months after treatment.
  
  
  RESULTS
  There was significant improvement in symptoms in both groups at 1 and 6 months after treatment. Ulnar motor nerve conduction velocity across the elbow improved at 1 month in Group A only, but showed improvement at 6 months in both groups. There was no significant change in the other parameters either at 1 or 6 months in both groups. In comparing the differences between Groups A and B regarding the changes at 1 or 6 months after treatment, there was no significant difference between the two groups in all parameters.
  
  
  CONCLUSIONS
  Splint application alone is adequate to improve the symptoms and ulnar nerve conduction across the elbow. The addition of a steroid injection did not provide further benefit in the treatment of cubital tunnel syndrome.
authors.affiliation: Department of Physical Medicine and Rehabilitation, University of California, Irvine, USA.
authors.forename: C Z
authors.initials: CZ
authors.lastname: Hong
authors.forename: H A
authors.initials: HA
authors.lastname: Long
authors.forename: R V
authors.initials: RV
authors.lastname: Kanakamedala
authors.forename: Y M
authors.initials: YM
authors.lastname: Chang
authors.forename: L
authors.initials: L
authors.lastname: Yates
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009408:Nerve Compression Syndromes / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D009431:Neural Conduction; D017063:Outcome Assessment, Health Care; D013165:Splints; D013997:Time Factors; D014221:Triamcinolone / Q000008:administration & dosage / Q000627:therapeutic use*; D014459:Ulnar Nerve / Q000503:physiopathology
chemical_list: D000893:Anti-Inflammatory Agents; D014221:Triamcinolone